Surface-exposed actin binds plasminogen on the membrane of agonist-activated platelets: a flow cytometry study by Tykhomyrov, A.A. et al.
172
A. A. Tykhomyrov, D. D. Zhernossekov, T. V. Grinenko
©  2017 A. A. Tykhomyrov et al.; Published by the Institute of Molecular Biology and Genetics, NAS of Ukraine on behalf 
of Biopolymers and Cell. This is an Open Access article distributed under the terms of the Creative Commons Attribution 
License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any 
medium, provided the original work is properly cited
UDC 577.151.6:576.311.348:576.52
Surface-exposed actin binds plasminogen on the membrane 
of agonist-activated platelets: a flow cytometry study
A. A. Tykhomyrov, D. D. Zhernossekov, T. V. Grinenko
Palladin Institute of Biochemistry, NAS of Ukraine 
9, Leontovycha Str., Kyiv, Ukraine, 01601 
artem_tykhomyrov@ukr.net
Aim. To elucidate whether actin exposed on the surface of agonist-activated platelets is re-
sponsible for plasminogen binding. Methods. Human washed platelets were obtained by 
gel-filtration on Sepharose-2B. The levels of exposed actin on the outer surface of plasma 
membrane of intact and thrombin- or collagen-stimulated platelets were monitored by flow 
cytometry. The binding of plasminogen fluorescent conjugate (Pg-FITC) with platelets treated 
with anti-actin antibody or non-immune IgG (control) was analyzed cytometrically. Results. 
Thrombin or collagen exposure resulted in the dose-dependent actin expression on the surface 
of stimulated platelets. Pre-treatment of stimulated platelets with specific anti-actin antibodies 
was shown to significantly prevent the binding of Pg-FITC with the platelet surface. Conclusion. 
The results of the present study indicate that actin exposed on the platelet surface at the agonist-
induced activation is involved in the plasminogen binding.
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Introduction
Platelets play a key role in hemostatic pro-
cess and regulate inflammatory and prolif-
erative events through releasing adhesive 
and coagulation proteins, growth factors and 
angiogenesis inhibitors. The platelet activa-
tion triggers cytoskeletal rearrangement that 
provides morphology changes, exocytosis, 
adhesion, aggregation, and retraction [1]. 
Activation also stimulates the expression of 
subcellular structures and novel proteins not 
detectable in the quiescent state on the out-
er surface of plasma membrane. There are 
several lines of independent evidences indi-
cating exposition of some cytoskeletal pro-
teins on the surface of agonist-stimulated 
platelets [2, 3]. Actin, a principal component 
of platelet cytoskeleton microfilaments, is 
among them [4]. However, the molecular 
mechanisms of actin translocation on the 
activated membrane and “external” functions 
of this major cytoskeletal protein are still 
obscure. 
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Plasminogen, a 92 kDa single-chain glyco-
protein, is an inactive proform of proteinase 
plasmin that dissolves fibrin in blood clots, 
acts as a proteolytic factor in tissue remodel-
ing, tumor invasion, and inflammation [5]. It 
has been well-documented that the binding of 
plasminogen to platelets is augmented by 
thrombin stimulation, suggesting exposure of 
additional binding sites on the activated mem-
brane [6]. It has been demonstrated during the 
experiments with pure proteins and with the 
use of cell culture models that plasminogen 
and actin interact with high extent of affinity. 
According to the data obtained by various 
research groups, Kd for the plasminogen-actin 
complex is about 70 – 140 nM [7]. These 
values are consistent with those describing the 
high-affinity interaction of plasminogen with 
actin exposed on PC12 cells [8]. Previously, 
actin has been identified on the surface of 
various normal and transformed cell types [see 
9, 10, 11 for summary]. For example, exter-
nally exposed actin has been observed on the 
sperm head, where it takes part in the process 
of membrane modification during sperm ca-
pacitation and initiation of acrosomal reac-
tion [12]. Moreover, actin located on the 
outer side of the plasma membrane has been 
found as a binding site for plasminogen. The 
Surface-expressed β/γ actin isoforms of cat-
echolaminegic cells are directly involved in 
the plasminogen activation, and resultant plas-
min promotes the formation of bioregulatory 
inhibitory peptides, thus modulating neu-
rotransmitter release [13]. Finally, β-actin 
expressed on the surface of some tumor cell 
lines (PC-3, HT1080, MDA-MB321), medi-
ates plasmin autoproteolysis resulting in the 
angiostatin AS 1–4.5 formation [7, 14]. It is 
logical to suppose that if the amounts of cell-
surface actin are related to its possible func-
tional activity, the surface actin expression 
may provide a subtle mechanism for regula-
tion of plasminogen binding. It should be 
further tested what kind of functional activi-
ties actin-bound plasminogen expresses on the 
platelet surface: is it involved in platelet sig-
naling or does it undergo proteolytic fragmen-
tation, resulting in the biologically active frag-
ments (angiostatins) formation? It is important 
to establish due to the fact that the interaction 
of plasminogen/plasmin system and platelets 
is considered as a crossroad between hemo-
stasis, tissue reparation and remodeling, 
wound healing, cell invasion, angiogenesis, 
and inflammation. There fore, this issue raises 
many questions, the dissection of which may 
shed light on a putative role of the actin-
plasminogen interactions on platelets in norm 
and their contribution to different pathological 
processes. 
We have previously developed and used 
flow cytometry assay to measure actin exposi-
tion on the platelet surface and observed that 
dynamic changes of this parameter directly 
depend on the agonist (thrombin) concentra-
tion [4]. The aim of this study is to test the 
hypothesis that the surface-exposed platelet 
actin can be involved in plasminogen binding, 
and thus to provide further evidence for of 
functional significance of platelet actin in such 
an unexpected location.
Materials and Methods
Chemicals
All chemicals and reagents were from Sigma 
Aldrich (USA) except for those specified.
174
A. A. Tykhomyrov, D. D. Zhernossekov, T. V. Grinenko
Plasminogen purification and plasmi­
no gen­fluorescein isothiocyanate (Pg­
FITC) conjugation
Native (Glu-) plasminogen was purified from 
fresh blood plasma of healthy donors by means 
of affine chromatography on lysine-sepharose, 
as described elsewhere [15]. Electrophoretically 
pure plasminogen was labeled with fluorescein 
isothiocyanate (FITC) to obtain fluorescent plas-
minogen conjugate (Pg-FITC), as previously 
described [16]. Neither plasminogen nor Pg-
FITC displays spontaneous proteolytic activity, 
as measured using the S2251 chromogenic assay. 
Research protocols were approved by the Ethical 
Committee of Palladin Institute of Biochemistry 
of NASU (3rd November, 2014, protocol no. 10).
Platelets
Washed platelets were obtained from human 
platelet-rich plasma by gel-filtration on 
Sepharose 2B as described elsewhere [17]. 
Informed consent was obtained from all donors 
(n = 3) in accordance with the Declaration of 
Helsinki, and ethical approval for the study 
was provided by the local ethics committee as 
mentioned above. To assess platelet viability 
and functional activity, platelet aggregation 
was measured by optical aggregometry (ag-
gregometer Solar AT-02, Republic of Belarus). 
All assays were performed within 60–80 min 
after platelet collection. Thrombin at final con-
centrations 0.1, 0.5 or 1.0 unit NIH/ml and 
collagen (Tekhnologia Standard, Russian 
Federation) at final concentrations 0.125 mg/
ml, 0.6 mg/ml or 1.25 mg/ml were used to 
stimulate platelets (5 × 106 platelets per sam-
ple). Platelets were incubated with agonists for 
5 min at 37 °C. The same amount of untreated 
(resting) platelets was used as a control.
Flow cytometry 
Flow cytometry assay was used as a sensitive 
and direct method for detection of actin surface 
expression and monitoring Pg-FITC binding 
with platelet surface. Platelet activation was 
stopped with 1 % paraformaldehyde in sodium 
phosphate buffered saline (PBS), pH 7.4, for 
20 min at room temperature, to prevent inter-
nalization of surface antigens and antibodies. 
Fixed platelets were washed with sodium-ci-
trate (3.8 %)-PBS and sodium-citrate (3.8 %)-
PBS containing 1 % BSA. Anti-actin antibody 
and anti-rabbit FITC-IgG were mixed in PBS 
in 1:80 and 1:200 dilutions, respectively (ac-
cording to manufacturer recommendations) 
and left for 30 min at 37 °C. Then, platelets 
were incubated with antibody mixture for 
30 min at 4 °C. Platelets incubated only with 
secondary FITC-conjugated antibody were 
used as a control for non-specific IgG binding 
(spontaneous, or background fluorescence). 
In this study, we prevented interaction of 
platelet-surface actin with Pg as a ligand by 
an anti-actin-antibody. Fixed platelets were 
treated with anti-actin antibodies for 30 min 
at room temperature, washed with PBS and 
labelled with Pg-FITC (in saturated concentra-
tion 100 μg/ml) in the same conditions. One 
sample of platelets was treated with non-im-
mune IgG as an isotype control. All procedures 
with labelled proteins were performed in the 
dark place to avoid photobleaching. After 
staining, platelets were washed from unbound 
antibodies or Pg-FITC twice with PBS by 
centrifugation at 1000 g for 3 min at 4 °C. 
Then, platelets were resuspended in 1 ml of 
PBS, and the percentage of FITC-positive 
platelets and intensity of specific FITC fluo-
rescence were monitored using of Coulter 
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Fig. 1. Flow cytometric analysis 
of platelet surface-exposed actin: 
A – representative dot plots show-
ing actin exposition on the outer 
side of plasma membrane of 
thrombin- or collagen-stimulated 
platelet; B and C – representative 
flow cytometry histograms of an-
ti-actin antibody binding to plate-
lets activated by thrombin or col-
lagen, respectively; D – values of 
FITC-signal intensities showing 
agonist concentration-dependent 
expression of platelet surface ac-
tin (the differences between each 
group vs. resting control are all 
statistically significant with P le-
vel no higher than 0.01).
A
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Epics XL device (Beckman Coulter, USA) via 
FL1 channel (515–535 nm). Population of 
untreated platelets was chosen for threshold 
value setting. Surface actin- or plasminogen-
positive platelet populations were gated sepa-
rately from the specific fluorescence-negative 
platelet population on the basis of sideward 
scattering (SSC). For control samples and 
thrombin-activated platelets, 15000 events 
were analysed, whereas for collagen-activated 
platelets at least 3000 events were analyzed 
due to high ability of collagen to cause plate-
let aggregation. Then the FITC-stained events 
found in the positive gate were expressed as 
the percentage of definition platelets. The mea-
surement of cytometric parameters in each 
group of platelets was carried out in duplicate, 
and the mean value was calculated based on 
the values obtained from all donors. Intensity 
values of FITC fluorescence were expressed 
as arbitrary units. The results were analyzed 
and presented using “FCS Express V3” soft-
ware system (De Novo Software, USA).
Statistical analysis
The results were expressed as mean ± standard 
error of mean (M ± m) or as medians for non-
normal distributions. The statistics were per-
formed with the use of Student’s t-test. 
Differences between parameters studied in 
each group were considered to be significant 
at P less than 0.05.
Results and Discussion
This study was performed to determine for the 
first time the role of surface-exposed actin in 
plasminogen binding by platelets. Earlier, we 
have performed flow cytometry assay to de-
termine if thrombin-activated platelets are able 
to expose actin on their surface [4]. Here, we 
extend that study and established the platelets, 
activated by thrombin or other potent natural 
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agonist, collagen, to represent actin-positive 
outer membrane. The results of cytometry 
sorting of platelets, presented in Fig. 1A, in-
dicate an increase in percentage of the spe-
cific fluorescence actin-positive platelets in 
response to the agonist action. If the samples 
of resting platelets contained up to 12 % of 
actin-presented species, the platelets after sub-
maximal (0.1 unit NIH/ml thrombin) stimula-
tion represented 88 % of actin-positive popu-
lation. The percentage of actin-positive plate-
lets reaches up to maximal value 94 and 98 % 
after incubation with 0.5 or 1.0 units NIH/ml 
of thrombin, respectively. The mean number 
of actin-presented platelets raised from 80 to 
90 % after stimulation with increasing collagen 
concentration (from 0.125 mg/ml to 1.25 mg/
ml). It is seen from Fig. 1B and C that throm-
bin, used in the indicated concentrations, in-
duced more intense actin surface expression 
compared to collagen. Measurements of fluo-
rescence signal values revealed a strong ago-
nist dose-dependent character of the actin ex-
position in platelets treated by thrombin in 
concentration of 0.1, 0.5 or 1.0 unit NIH/ml, 
which was respectively 30-, 54- and 143-fold 
higher in comparison with this level for un-
treated platelets (Fig. 1D). However, collagen 
stimulation caused a lesser extent of the actin 
exposition that maximally reached only 24-fold 
increment in the case of application of the 
highest concentration (1.25 mg/ml). These 
differences between the thrombin- and colla-
gen-induced actin expositions are probably 
related to the activation of distinct signal path-
ways responsible for cytoskeleton rearrange-
ment in platelets.
In the present work, we unequivocally 
established that the agonist-induced exposi-
tion of actin contributes to the plasminogen 
interaction with activated platelets. 
Interestingly, there is only limited population 
of resting platelets (~ 35 % of total amount 
of platelets), which appeared to be able to 
bind plasminogen (Fig. 2A). In contrast, both 
thrombin and collagen in their maximal con-
centrations (1.0 U NIH/ml and 1.25 mg/ml, 
respectively) dramatically increase the quan-
tity of Pg-FITC-positive platelets (in average, 
94.4 and 95.2 %, respectively). However, as 
shown by the intensity signal curve analysis, 
the plasminogen-binding ability of the colla-
gen-exposed platelets appeared to be much 
weaker than that for of thrombin-activated 
counterparts (Fig. 2 B and C). Notably, actin 
blockade by inhibitory antibodies insignifi-
cantly lowered the quantity of Pg-FITC-
binding platelets. Thus, 93.8 and 84.9 % of 
thrombin- or collagen-stimulated platelets, 
respectively, remained to be gated as FITC-
positive events. However, the intensity signal 
from fluorescence conjugate bound to plate-
lets decreased 4- and 2.5-fold in the ca ses of 
thrombin- or collagen-activated platelets, cor-
respondently, Fig. 2D). These data mean that, 
apart from actin, other molecular targets also 
mediate the plasminogen interactions with the 
surface of activated platelets. It has been 
earlier reported that there are several mole-
cules on the platelet surface, which ensure 
plasminogen binding, including integrins 
(αMβ2, α5β1, αVβ3, αIIbβ3), fibrinogen, fi-
bronectin, vitronectin, and laminin 18.
The presence of cytoskeletal proteins on the 
cell surface has been reported in several other 
studies [19, 20]. However, the mechanisms of 
actin export on the cell surface are still obscure 
and it must be determined how actin, which 
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lacks a classical signal sequence, moves to the 
cell surface and anchors to the plasma mem-
brane. The authors [21] hypothesize the exis-
tence of specific mechanisms of actin transport 
in a complex with other proteins acting as 
carriers. For example, gelsolin being actin-
binding protein is considered as a plausible 
candidate for the role of actin transporter be-
cause it can penetrate plasma due to a special 
signal peptide. Interestingly, the actin exposi-
Fig. 2. Flow cytometric analysis of plasminogen binding with platelet surface: A – representative dot plots indicating 
inhibitory effects of anti-actin antibodies on Pg-FITC binding by activated platelets; B and C – representative flow 
cytometry histograms of Pg-FITC showing effects of pre-incubation with anti-actin antibodies on Pg-FITC fluores-
cence intensity pattern for platelets activated by thrombin or collagen, respectively; D – values of signal intensities 
captured from FITC-positive platelets reflecting actin exposition in plasminogen binding (# – P < 0.001 compared to 
thrombin-stimulated platelets, * – P < 0.05 compared to collagen-exposed platelets).
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tion on the surface of some cancer cells is 
thought to be an attribute of their apoptotic 
changes, in which actin has been shown to play 
an important role. For instance, the cells of 
medullary breast carcinoma expose surface 
actin, which is accumulated in the region of 
apoptotic blebs [22]. It is well-known that the 
outside-in agonist-mediated signaling triggers 
actin cytoskeleton reorganization in platelets, 
and actin appearance on the platelet surface 
may be associated with the lipid rafts forma-
tion, membrane blebbing and exocytosis [23].
Actin is a 42 kDa structurally highly con-
served protein that occurs in all eukaryotic 
cells. Human platelet actin is represented by 
β- and γ-isoforms, like in most non-muscle 
cells [25]. All isoforms are very similar at the 
sequence level and therefore all of them have 
been shown to bind plasminogen. The residues 
Lys61, 68 and 113, which are highly conserva-
tive and occur in all actin isoforms, are respon-
sible for the plasminogen recognition. The 
residue Lys61 is the most important for the 
interaction with plasminogen because it is 
situated on the surface of the actin globule. 
Moreover, proteolytic processing at the 
C-terminus of actin resulting in the Lys373 
exposure increases affinity of plasminogen-
actin binding and stimulates the cell-dependent 
plasminogen activation. In turn, the Lys-
binding sites of plasminogen-plasmin kringle 
domains are involved in interaction with actin 
that can be inhibited by lysine and its ana-
logues [10, 13]. 
Plasminogen as a plasmin precursor plays 
the major role in blood clot fibrinolysis. 
However, the current researches emphasize 
that plasminogen is involved in the regulation 
of the functional state of various cell types 
affecting different cellular components and 
signal pathways [25]. Our previous data have 
shown that the partially truncated Lys-form of 
plasminogen is able to interrupt the cytoskel-
eton remodelling, to affect the platelet de-
granulation, and to inhibit the agonist-induced 
platelet aggregation [26, 27]. Native (Glu-) 
plasminogen facilitates phosphatidylserine ex-
posure on the surface of thrombin- or collagen-
activated human platelets, thus promoting the 
formation of the platelet procoagulant sur-
face [28]. Based on the data of Miles and 
other s [13], it can be assumed that the cell-
surface forms of actin may be involved in the 
pericellular plasminogen activation to plasmin 
as a binding site for proenzyme. The potential 
of platelets to enhance fibrinolysis by local-
izing plasminogen in the vicinity of a fibrin 
clot is in agreement with this observation [6]. 
Indeed, in the membrane-associated state, plas-
minogen acquires open conformation that is 
more readily converted into plasmin, which is 
able to further modulate the platelet response 
to thrombin and other aggregating agents that 
is influenced by its concentration [29]. 
Participation of surface-expressed actin in the 
plasminogen activation is additionally sup-
ported by the data demonstrating inhibitory 
effects of specific anti-actin antibodies on the 
cell-dependent plasminogen activation [13]. 
On the other hand, the activated platelets have 
been shown to secret and/or generate de novo 
proteolytically-derived plasminogen frag-
ments, referred to as angiostatins, due to plas-
min autoproteolysis. The mechanism of actin-
mediated angiostatin formation can represent 
the way, in which platelets may regulate re-
parative angiogenesis, thus counteracting pro-
angiogenic stimuli [30]. 
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Interestingly, actin is not the only cytoskel-
etal protein found in such an unusual location. 
It has been observed previously that the acti-
vated platelets presented one more cytoskel-
etal protein, vimentin, the major component 
of intermediate filaments. Vimentin exposed 
upon the platelet activation may serve to loca-
li ze complexes [vitronectin – plasminogen 
activator inhibitor type I (PAI-I)] on the plate-
let surface. In summary, our research is one of 
the attempts performed to uncover the func-
tional link existing between the platelet cyto-
skeleton and the plasminogen/plasmin system. 
We are currently undertaking studies to exam-
ine whether the interaction between actin and 
plasminogen on the platelet surface may, at 
least partially, contribute to the regulation of 
processes related to platelet physiology.
Conclusions 
Herein, we provide for the first time direct 
evidence that surface-exposed actin is respon-
sible for increased plasminogen binding with 
the surface of activated platelets. It can be 
summarized that the levels of surface-exposed 
actin may reflect the functional competence of 
platelets in plasminogen binding. 
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Роль експонованого актину у зв’язуванні 
плазміногену на мембрані агоніст-активованих 
тромбоцитів: цитометричне дослідження
А. О. Тихомиров, Д. Д. Жерносєков, 
Т. В. Гриненко 
Мета. З’ясувати здатність актину, що експонується на 
поверхні тромбоцитів, активованих різними агоніста-
ми, зв’язувати плазміноген. Методи. Відмиті тромбо-
цити людини отримували за допомогою гель-фільтрації 
на Сефарозі-2В. Кількісну оцінку експонування акти-
ну на зовнішній поверхні інтактних тромбоцитів та 
тромбоцитів, активованих тромбіном або колагеном, 
проводили із застосуванням протокової цитометрії. 
Зв’язування флуоресцентного кон’югату плазміноген-
FITC (Pg-FITC) з тромбоцитами, обробленими анти-
тілами проти актину або неімунними IgG (контроль), 
аналізували цитометрично. Результати. Вплив тром-
біну та колагену призводить до появи на зовнішньому 
боці плазматичної мембрани тромбоцитів актину, кіль-
кість якого залежала від концентрації агоністів. 
Попередня обробка активованих тромбоцитів специ-
фічними антитілами проти актину значно запобігала 
зв’язуванню Pg-FITC з поверхнею тромбоцитів. 
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Висновки. Результати представленого дослідження 
вказують на залучення експонованого актину до 
зв’язування плазміногену на поверхні тромбоцитів, 
стимульованими різними агоністами.
Ключов і   слова: тромбоцити, експонований актин, 
плазміноген, протокова цитометрія
Роль экспонированного актина в связывании 
плазминогена на мембране агонист-
активированных тромбоцитов: 
цитометрическое исследование
А. А. Тихомиров, Д. Д. Жерносеков, 
Т. В. Гриненко
Цель. Выяснить способность актина, который экспо-
нируется на поверхности тромбоцитов, активирован-
ных различными агонистами, связывать плазминоген. 
Методы. Отмытые тромбоциты человека получали с 
помощью гель-фильтрации на Сефарозе-2В. Коли чест-
венную оценку экспонирования актина на внешней 
поверхности интактных тромбоцитов и тромбоцитов, 
активированных тромбином или коллагеном, прово-
дили с использованием проточной цитометрии. 
Связывание флуоресцентного конъюгата плазмино-
ген-FITC (Pg-FITC) с тромбоцитами, обработанными 
антителами против актина или неимунными IgG (кон-
троль), анализировали цитометрически. Результаты. 
Влияние тромбина и коллагена приводило к появлению 
на внешней стороне плазматической мембраны тром-
боцитов актина, количество которого зависело от кон-
центрации агонистов. Предварительная обработка 
активированных тромбоцитов специфическими анти-
телами против актина в значительной степени предот-
вращала связывание Pg-FITC с поверхностью тромбо-
цитов. Выводы. Результаты представленного иссле-
дования указывают на вовлечение экспонированного 
актина в связывание плазминогена на поверхности 
тромбоцитов, стимулированных различными агони-
стами.
Ключевые  слова: тромбоциты, экспонированный 
актин, плазминоген, проточная цитометрия 
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